Clinical trial
Cisplatin, Carboplatin, and Oxaliplatin Interactions With Plasma Proteins
NCT00131586 · AHS Cancer Control Alberta, Other · Terminated
Key facts
| NCT number | NCT00131586 |
|---|---|
| Title | Cisplatin, Carboplatin, and Oxaliplatin Interactions With Plasma Proteins |
| Official title | Cisplatin, Carboplatin, and Oxaliplatin Interactions With Plasma Proteins |
| Lead sponsor | AHS Cancer Control Alberta, Other |
| Status | Terminated |
| Study type | Observational |
| Conditions | Lung Cancer, Colorectal Cancer |
| Enrollment | 100 |
| Start date | Apr 1, 2003 |
| Primary completion | Feb 1, 2009 |
| Completion | Feb 1, 2009 |
| First posted | Aug 19, 2005 |
| Last update posted | Feb 26, 2016 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: